查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1338919

毛里尔病市场、份额、市场规模、趋势、行业分析报告：按治疗、按应用、按最终用户、按地区、按细分市场预测，2023-2032 年

Darier Disease Market Share, Size, Trends, Industry Analysis Report, By Treatment (Medication, Surgery, and Others); By Application; By End- User; By Region; Segment Forecast, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 112 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球毛病市场规模预计将达到7,412万美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

随着新的医疗趋势的出现，Darrier 病预计将变得更加普遍。 将有更多的皮肤病治疗方法来解决这种疾病的副作用，研究人员可能会获得大量的财务支持来创造新的治疗方法。 Darier 病（毛囊角化症）是一种罕见的遗传性皮肤病，由 ATP2A2 基因突变引起。 此疾病的特征是疣状丘疹或斑块，通常出现在头皮、前额、胸部、背部和身体其他部位。

由于这种疾病的罕见性，达里尔病的市场极小。 然而，包括 Castle Creek Pharmaceuticals 和 Hoss Therapeutics 在内的某些公司专注于开发罕见皮肤病的治疗方法。 事实上，一些用于治疗达里尔病的药物，如类维生素A和钙调神经磷酸□抑制剂，也用于治疗其他皮肤病，这可能有助于扩大这些药物的市场。

不过，由于罕见疾病药物的患者数量较少且开发成本较高，投资该领域的公司数量可能会受到限制。 COVID-19 的爆发对医疗保健产业产生了重大影响，许多医疗保健提供者和设施致力于治疗 COVID-19 患者。 这导致了其他疾病的诊断和治疗的延误，包括达里尔病等罕见疾病。 此外，疫情可能会扰乱临床试验和药物开发计划，影响达里尔病新疗法的可用性。 由于安全问题和患者进入医疗机构的机会有限，许多临床试验已被推迟或停止。

Drier 疾病市场报告亮点

预计在预测期内，外科手术将主导该行业的细分市场。 外科手术在减少疼痛和不适的同时改善结果的能力是行业扩张的主要驱动力。

外用类维生素A预计将在明年占据较高的市场份额。 作为市场驱动因素，这些药物治疗症状的有效性预计将在未来几年内成长。

2022年皮肤科医师占占比最大。 他们开处方、为患者提供支持，并在这种疾病的治疗中发挥关键作用，使他们成为影响市场的主要力量。

预计北美的需求在预测期内将大幅成长。 由于医疗服务选择范围扩大和医疗成本上升等多种因素，预计未来几年市场的主要驱动力将成长。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第 4 章全球乳牛病市场洞察

  • Darrier 疾病市场 - 最终用户快照
  • Drier病市场动态
    • 推动者和机会
      • 对再生能源的需求不断增加
      • 电力消耗需求增加
    • 抑制因素和挑战
      • 初始成本高
  • PESTEL 分析
  • Darier 疾病市场的最终用户趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第五章全球乳牛病市场（依治疗）

  • 主要发现
  • 简介
  • 医学
  • 手术
  • 其他

第 6 章全球乳牛病市场，依应用划分

  • 主要发现
  • 简介
  • 外用维A酸
  • 口服维A酸
  • 其他

第 7 章最终使用者的全球乳牛病市场

  • 主要发现
  • 简介
  • 皮肤科医生
  • 居家护理
  • 医院
  • 专科诊所

第 8 章全球乳牛病市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年按地区划分的Darrier 疾病市场评估
  • Darrier 疾病市场 - 北美
    • 北美：乳牛病市场，依治疗方法，2019-2032 年
    • 北美：达里尔疾病市场，按最终用户划分，2019-2032 年
    • 北美：乳牛疾病市场，依应用划分，2019-2032 年
    • Darrier 疾病市场 - 美国
    • Drier 疾病市场 - 加拿大
  • Drier 疾病市场 - 欧洲
    • 欧洲：2019-2032 年乳牛病市场（依治疗方法）
    • 欧洲：达里尔疾病市场，以最终用户划分，2019-2032 年
    • 欧洲：乳牛疾病市场，依应用划分，2019-2032 年
    • Drier 疾病市场 - 英国
    • Drier 疾病市场 - 法国
    • Drier 疾病市场 - 德国
    • Darrier 疾病市场 - 义大利
    • Darrier 疾病市场 - 西班牙
    • Drier 疾病市场 - 荷兰
    • Drier 疾病市场 - 俄罗斯
  • Darrier 疾病市场 - 亚太地区
    • 亚太地区：乳牛病市场（依治疗方法），2019-2032 年
    • 亚太地区：毛病市场，依最终使用者划分，2019-2032 年
    • 亚太地区：乳牛疾病市场，依应用划分，2019-2032 年
    • Darrier 疾病市场 - 中国
    • Drier 疾病市场 - 印度
    • Drier 疾病市场 - 马来西亚
    • Darrier 疾病市场 - 日本
    • Darrier 疾病市场 - 印度尼西亚
    • Darrier 疾病市场 - 韩国
  • Darrier 疾病市场 - 中东和非洲
    • 中东和非洲：2019-2032 年毛里尔病市场（依治疗方法）
    • 中东和非洲：2019-2032 年达里尔疾病市场（按最终用户划分）
    • 中东和非洲：毛病市场，按应用划分，2019-2032 年
    • Drier 疾病市场 - 沙乌地阿拉伯
    • Darrier 疾病市场 - 阿拉伯联合大公国
    • Drier 疾病市场 - 以色列
    • Drier 疾病市场 - 南非
  • Darrier 疾病市场 - 拉丁美洲
    • 拉丁美洲：水牛病市场（依治疗方法），2019-2032 年
    • 拉丁美洲：达里尔疾病市场，按最终用户划分，2019-2032 年
    • 拉丁美洲：乳牛病市场，按应用划分，2019-2032 年
    • Drier 疾病市场 - 墨西哥
    • Drier 疾病市场 - 巴西
    • Drier 疾病市场 - 阿根廷

第九章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第十章公司简介

  • AbbVie
  • Amneal Pharmaceuticals
  • Bausch Health Companies
  • BridgeBio Pharma
  • Galderma
  • GlaxoSmithKline
  • Glenmark Pharmaceuticals
  • Johnson and Johnson
  • Laminar Pharma
  • Mayne Pharma
  • Merck
  • Novartis
  • Pfizer
  • Sawai Pharmaceutical
  • Sigmapharm Laboratories
  • Sun Pharmaceutical
  • Teva Pharmaceutical
  • Tolmar Pharmaceuticals
  • Validus Pharmaceuticals
  • Viatris
Product Code: PM3363

The global darier disease market size is expected to reach USD 74.12 million by 2032, according to a new study by Polaris Market Research. The report "Darier Disease Market Share, Size, Trends, Industry Analysis Report, By Treatment (Medication, Surgery, and Others); By Application; By End- Use; By Region; Segment Forecast, 2023-2032" gives a detailed insight into the current market dynamics and provides analysis on future market growth.

Darier disease is anticipated to spread as new healthcare trends emerge. More dermatological treatments will be available to address the condition's side effects, and researchers will receive sizeable financial support to create novel remedies. Darier disease, or keratosis follicularis, is a rare genetic skin disorder caused by mutations in the ATP2A2 gene. The disease is characterized by wart-like papules and plaques that typically appear on the scalp, forehead, chest, back, and other body areas.

Due to the condition's rarity, the market for Darier disease is quite small. Yet, certain businesses, including Castle Creek Pharmaceuticals & Hoth Therapeutics, are focused on creating treatments for uncommon skin conditions. The fact that some of the medications used to treat Darier disease, including retinoids and calcineurin inhibitors, are also used to treat other skin disorders may help to increase the market for these medications.

However, the small patient population and the high cost of developing rare disease therapies may limit the number of companies investing in this area. The COVID-19 pandemic has significantly impacted the healthcare industry, with many healthcare providers and facilities focused on treating patients with COVID-19. This has led to delays in diagnosing and treating other medical conditions, including rare diseases like Darier disease. Additionally, the pandemic has disrupted clinical trials and drug development programs, which may impact the availability of new treatments for Darier disease. Many trials have been delayed or suspended due to safety concerns and restrictions on patient access to healthcare facilities.

Darier Disease Market Report Highlights

Surgery is expected to dominate the industry's market sector during forecast period. The ability of the surgical industry to reduce pain and discomfort while improving results is the major factor driving its expansion.

Topical Retinoid will account for a higher share of the market in the upcoming year. Due to the effectiveness of these medications in treating the condition's symptoms, the primary driver driving the market is predicted to grow over the next several years.

Dermatologist accounted for the largest share in 2022. They are the primary force influencing the market because they are in charge of prescribing, offering patient support, and playing a crucial part in the care of this ailment.

The demand in North America is expected to witness significant growth during forecast period. The primary driver of the market is anticipated to rise in the upcoming years as a result of a number of factors, including the expansion of healthcare service options and rising healthcare costs.

Polaris Market Research has segmented the Darier Disease Market report based on treatment, application, end- user and region:

Darier Disease, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

  • Medical
  • Surgery
  • Others

Darier Disease, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Topical Retinoids
  • Oral Retinoids
  • Others

Darier Disease, End- User Outlook (Revenue - USD Million, 2019 - 2032)

  • Dermatologist
  • Homecare
  • Hospitals
  • Specialty Clinics

Darier Disease, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Darier Disease Market Insights

  • 4.1. Darier Disease Market - End- User Snapshot
  • 4.2. Darier Disease Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in demand for renewable sources of energy
      • 4.2.1.2. Rise in demand for electricity consumption
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High initial costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Darier Disease Market End- User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Darier Disease Market, by Treatment

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • 5.3. Medical
    • 5.3.1. Global Darier Disease Market, by Medical, by Region, 2019-2032 (USD Million)
  • 5.4. Surgery
    • 5.4.1. Global Darier Disease Market, by Surgery, by Region, 2019-2032 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Darier Disease Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Darier Disease Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 6.3. Topical Retinoids
    • 6.3.1. Global Darier Disease Market, by Topical Retinoids, by Region, 2019-2032 (USD Million)
  • 6.4. Oral Retinoids
    • 6.4.1. Global Darier Disease Market, by Oral Retinoids, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Darier Disease Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Darier Disease Market, by End- User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • 7.3. Dermatologist
    • 7.3.1. Global Darier Disease Market, by Dermatologist, By Region, 2019-2032 (USD Million)
  • 7.4. Homecare
    • 7.4.1. Global Darier Disease Market, by Homecare, By Region, 2019-2032 (USD Million)
  • 7.5. Hospitals
    • 7.5.1. Global Darier Disease Market, by Hospitals, By Region, 2019-2032 (USD Million)
  • 7.6. Specialty Clinics
    • 7.6.1. Global Darier Disease Market, by Specialty Clinics, By Region, 2019-2032 (USD Million)

8. Global Darier Disease Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Darier Disease Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Darier Disease Market - North America
    • 8.3.1. North America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.2. North America: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.3.3. North America: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.3.4. Darier Disease Market - U.S.
      • 8.3.4.1. U.S.: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.3.5. Darier Disease Market - Canada
      • 8.3.5.1. Canada: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 8.4. Darier Disease Market - Europe
    • 8.4.1. Europe: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.4. Darier Disease Market - UK
      • 8.4.4.1. UK: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.5. Darier Disease Market - France
      • 8.4.5.1. France: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.6. Darier Disease Market - Germany
      • 8.4.6.1. Germany: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.7. Darier Disease Market - Italy
      • 8.4.7.1. Italy: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.8. Darier Disease Market - Spain
      • 8.4.8.1. Spain: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.9. Darier Disease Market - Netherlands
      • 8.4.9.1. Netherlands: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.10. Darier Disease Market - Russia
      • 8.4.10.1. Russia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 8.5. Darier Disease Market - Asia Pacific
    • 8.5.1. Asia Pacific: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.4. Darier Disease Market - China
      • 8.5.4.1. China: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.5. Darier Disease Market - India
      • 8.5.5.1. India: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.6. Darier Disease Market - Malaysia
      • 8.5.6.1. Malaysia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.7. Darier Disease Market - Japan
      • 8.5.7.1. Japan: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.8. Darier Disease Market - Indonesia
      • 8.5.8.1. Indonesia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.9. Darier Disease Market - South Korea
      • 8.5.9.1. South Korea: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 8.6. Darier Disease Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.6.4. Darier Disease Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.6.5. Darier Disease Market - UAE
      • 8.6.5.1. UAE: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.6.6. Darier Disease Market - Israel
      • 8.6.6.1. Israel: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.6.7. Darier Disease Market - South Africa
      • 8.6.7.1. South Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 8.7. Darier Disease Market - Latin America
    • 8.7.1. Latin America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.7.4. Darier Disease Market - Mexico
      • 8.7.4.1. Mexico: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.7.5. Darier Disease Market - Brazil
      • 8.7.5.1. Brazil: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.7.6. Darier Disease Market - Argentina
      • 8.7.6.1. Argentina: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Darier Disease Market, by Application, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Amneal Pharmaceuticals
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bausch Health Companies
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. BridgeBio Pharma
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Galderma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. GlaxoSmithKline
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Glenmark Pharmaceuticals
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson and Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Laminar Pharma
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Mayne Pharma
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Merck
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Novartis
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Pfizer
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Sawai Pharmaceutical
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Sigmapharm Laboratories
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. Sun Pharmaceutical
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
  • 10.17. Teva Pharmaceutical
    • 10.17.1. Company Overview
    • 10.17.2. Financial Performance
    • 10.17.3. Product Benchmarking
    • 10.17.4. Recent Development
  • 10.18. Tolmar Pharmaceuticals
    • 10.18.1. Company Overview
    • 10.18.2. Financial Performance
    • 10.18.3. Product Benchmarking
    • 10.18.4. Recent Development
  • 10.19. Validus Pharmaceuticals
    • 10.19.1. Company Overview
    • 10.19.2. Financial Performance
    • 10.19.3. Product Benchmarking
    • 10.19.4. Recent Development
  • 10.20. Viatris
    • 10.20.1. Company Overview
    • 10.20.2. Financial Performance
    • 10.20.3. Product Benchmarking
    • 10.20.4. Recent Development

List of Tables

  • Table 1 Global Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 2 Global Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 3 Global Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 4 Darier Disease Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 6 North America: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 7 North America: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 8 U.S.: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 9 U.S.: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 10 U.S.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 11 Canada: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 12 Canada: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 13 Canada: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 14 Europe: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 15 Europe: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 16 Europe: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 17 UK: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 18 UK: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 19 UK: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 20 France: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 21 France: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 22 France: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 23 Germany: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 24 Germany: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 25 Germany: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 26 Italy: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 27 Italy: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 28 Italy: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 29 Spain: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 30 Spain: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 31 Spain: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 33 Netherlands: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 34 Netherlands: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 35 Russia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 36 Russia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 37 Russia: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 41 China: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 42 China: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 43 China: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 44 India: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 45 India: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 46 India: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 48 Malaysia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 49 Malaysia: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 50 Japan: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 51 Japan: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 52 Japan: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 54 Indonesia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 55 Indonesia: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 56 South Korea: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 57 South Korea: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 58 South Korea: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 65 UAE: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 66 UAE: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 67 UAE: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 68 Israel: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 69 Israel: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 70 Israel: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 71 South Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 72 South Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 73 South Africa: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 74 Latin America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 75 Latin America: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 76 Latin America: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 77 Mexico: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 78 Mexico: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 79 Mexico: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 80 Brazil: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 81 Brazil: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 82 Brazil: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 83 Argentina: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 84 Argentina: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 85 Argentina: Darier Disease Market, by End- User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Darier Disease Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Darier Disease Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8. Market by Treatment
  • Figure 9. Global Darier Disease Market, by Treatment, 2022 & 2032 (USD Million)
  • Figure 10. Market by End- User
  • Figure 11. Global Darier Disease Market, by End- User, 2022 & 2032 (USD Million)
  • Figure 12. Darier Disease Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Darier Disease Market